I
I. Aumann
Researcher at Leibniz University of Hanover
Publications - 15
Citations - 322
I. Aumann is an academic researcher from Leibniz University of Hanover. The author has contributed to research in topics: Smoking cessation & Cost effectiveness. The author has an hindex of 7, co-authored 15 publications receiving 233 citations. Previous affiliations of I. Aumann include Hannover Medical School.
Papers
More filters
Journal ArticleDOI
Applying the Analytic Hierarchy Process in healthcare research: A systematic literature review and evaluation of reporting.
Katharina Schmidt,I. Aumann,Ines Hollander,Kathrin Damm,J.-Matthias Graf von der Schulenburg +4 more
TL;DR: The Analytic Hierarchy Process has been applied inconsistently in healthcare research and new insights are needed to determine which target group can best handle the challenges of the AHP.
Journal ArticleDOI
Patient- and person-reports on healthcare: preferences, outcomes, experiences, and satisfaction – an essay
TL;DR: The new classification system includes patient- and person-reported preferences, outcomes, experiences, and satisfaction related to healthcare and health outcomes, and the most constitutive methods to measure these four categories have been described in this article.
Journal ArticleDOI
Maßnahmen zur Verbesserung der gesundheitlichen Situation von Menschen mit seltenen Erkrankungen in Deutschland
Martin Frank,Daniela Eidt-Koch,I. Aumann,A. Reimann,Thomas O. F. Wagner,J.-M. Graf von der Schulenburg +5 more
TL;DR: The aim of this paper is to present the main recommendations of this research report and relate it to current developments in the field of medical care for people with rare diseases.
Journal ArticleDOI
Trade-off between benefits, harms and economic efficiency of low-dose CT lung cancer screening: a microsimulation analysis of nodule management strategies in a population-based setting.
M Treskova,I. Aumann,I. Aumann,Heiko Golpon,Jens Vogel-Claussen,Tobias Welte,Alexander Kuhlmann +6 more
TL;DR: Lung cancer screening can be cost-effective in Germany and definition of the thresholds for nodule size and nodule growth in the nodule management protocol should be considered in detail when defining optimal screening strategies.
Journal ArticleDOI
[Epidemiology and costs of asthma in Germany - a systematic literature review].
TL;DR: Im Bereich der Krankheitskostenstudien ist aufgrund geringer Aktualitat and methodischer Schwachen weiterer Forschungsbedarf zu sehen, anderswo die Erstellung einer Ubersicht der Evidenz zur Pravalenz zur Inzidenz von Asthma bronchiale fur Deutschland zu identifizieren.